Levothyroxine Export Market Intelligence: India's 125 Suppliers Shipping to 71 Countries — TransData Nexus 2026

Q: Who are the top levothyroxine exporters from India?

The top levothyroxine exporters from India are: 1. MACLEODS PHARMACEUTICALS LTD — $25.6M (32.9% market share); 2. INTAS PHARMACEUTICALS LIMITED — $14.7M (18.9% market share); 3. STERIL-GENE LIFE SCIENCES PRIVATE LIMITED — $9.4M (12.1% market share); 4. WOCKHARDT LIMITED — $5.9M (7.6% market share); 5. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $4.9M (6.3% market share). Together they account for 77.8% of India's total levothyroxine export value.

Q: What is the total export value of levothyroxine from India?

The total export value of levothyroxine from India is $77.7M USD, recorded across 2,385 shipment transactions from 125 active exporters to 71 destination countries. The average shipment value is $32.6K.

Q: Which countries import levothyroxine from India?

India exports levothyroxine to 71 countries worldwide. The top importing countries are: UNITED STATES (63.6% share, $49.4M), PERU (11.6% share, $9.0M), UNITED KINGDOM (8.8% share, $6.8M), AUSTRALIA (6.9% share, $5.3M), CHILE (2.4% share, $1.8M). These five markets account for 93.3% of total export value.

Q: What is the average price of levothyroxine exports from India?

The average unit price for levothyroxine exports from India is $1.77 USD per unit, with prices ranging from $0.00 to $239.32 depending on formulation, packaging, and order volume. The total market is valued at $77.7M across 2,385 shipments.

Q: Which ports handle levothyroxine exports from India?

The primary ports for levothyroxine exports from India are SAHAR AIR CARGO ACC (INBOM4) (10.8% of shipments), MUNDRA SEA (10.8% of shipments), DELHI AIR CARGO ACC (INDEL4) (8.7% of shipments), NHAVA SHEVA SEA (INNSA1) (8.7% of shipments), MUNDRA SEA (INMUN1) (7.5% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of levothyroxine?

India is one of the world's leading exporters of levothyroxine due to its large base of 125 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports levothyroxine to 71 countries, demonstrating 36% global market coverage.

Q: What certifications do Indian levothyroxine exporters need?

Indian levothyroxine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import levothyroxine from India?

There are 235 registered buyers importing levothyroxine from India, spread across 71 countries. The repeat buyer rate is 66.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top levothyroxine supplier from India?

MACLEODS PHARMACEUTICALS LTD is the leading levothyroxine exporter from India with a market share of 32.9% and total export value of $25.6M across 278 shipments. The top 5 suppliers together control 77.8% of total export value.

Suresh Sormare

Levothyroxine

India Pharmaceutical Trade Intelligence

$77.7M125 Suppliers71 CountriesHS 30049099

ExportsIndia → UNITED STATES63.6%India → PERU11.6%

ImportsUNITED STATES → India$551.1K BELGIUM → India$196.2K

#1 Buyer: MACLEODS PHARMA

Levothyroxine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Levothyroxine to the World

Between 2022 and 2026, India exported $77.7M worth of levothyroxine across 2,385 verified shipments to 71 countries — covering 36% of world markets in the Diabetes & Endocrine segment. The largest destination is UNITED STATES (63.6%). MACLEODS PHARMACEUTICALS LTD leads with a 32.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Levothyroxine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Levothyroxine export data snapshot — $77.7M · 125 exporters · 71 countriesTransData Nexus · Indian Customs Data

Top Levothyroxine Exporters from India

125 active exporters · Ranked by export value

View all 125 →

Top Levothyroxine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MACLEODS PHARMACEUTICALS LTD	$25.6M	278	14	32.9%
2	INTAS PHARMACEUTICALS LIMITED

Top Countries Importing Levothyroxine from India

71 destination markets · Ranked by import value

All 71 countries →

Top Countries Importing Levothyroxine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$49.4M	63.6%
2	PERU	$9.0M	11.6%
3	UNITED KINGDOM	$6.8M	8.8%
4	AUSTRALIA	$5.3M	6.9%
5	CHILE	$1.8M	2.4%
6	CANADA	$1.5M	2.0%
7	KAZAKHSTAN	$1.1M	1.4%
8	DOMINICAN REPUBLIC	$528.6K	0.7%
9	SRI LANKA	$342.4K	0.4%
10	VIETNAM	$325.6K	0.4%

UNITED STATES is India's largest levothyroxine export destination, absorbing 63.6% of total exports worth $49.4M. The top 5 importing countries — UNITED STATES, PERU, UNITED KINGDOM, AUSTRALIA, CHILE — together account for 93.3% of India's total levothyroxine export value. The remaining 66 destination countries collectively receive the other 6.7%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Levothyroxine to India?

13 origin countries · Total import value: $797.0K

India imports levothyroxine from 13 countries with a combined import value of $797.0K. The largest supplier is UNITED STATES ($551.1K, 220 shipments), followed by BELGIUM and AUSTRALIA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Levothyroxine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$551.1K	220	69.1%
2	BELGIUM	$196.2K	3	24.6%
3	AUSTRALIA	$12.2K	15	1.5%
4	CANADA	$10.6K	52	1.3%
5	ITALY	$7.8K	24	1.0%
6	GERMANY	$7.7K	28	1.0%
7	BRAZIL	$3.4K	11	0.4%
8	UNITED KINGDOM	$3.4K	9	0.4%
9	MEXICO	$1.9K	4	0.2%
10	SWITZERLAND	$1.6K	2	0.2%

Showing top 10 of 13 origin countries

UNITED STATES is the largest supplier of levothyroxine to India, accounting for 69.1% of total import value. The top 5 origin countries — UNITED STATES, BELGIUM, AUSTRALIA, CANADA, ITALY — together supply 97.6% of India's levothyroxine imports. Click any country to see detailed supplier and buyer data for that import corridor.

Levothyroxine — Export Intelligence Video

Visual overview of India's levothyroxine import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's levothyroxine pharmaceutical import and export market — $77.7M in total trade, 125 verified manufacturers, and 71 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Levothyroxine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Levothyroxine sodium, a synthetic thyroid hormone, is extensively utilized in the United States for the treatment of hypothyroidism and other thyroid-related disorders. The FDA has approved numerous Abbreviated New Drug Applications (ANDAs) for generic formulations of levothyroxine tablets, indicating a well-established market presence. However, as of February 2026, the FDA has not approved generic versions of certain oral solution formulations, such as Ermeza, Thyquidity, and Tirosint-Sol. For instance, Ermeza, approved on April 29, 2022, remains without a generic counterpart due to existing patent protections.

The regulatory pathway for levothyroxine involves stringent bioequivalence requirements due to its narrow therapeutic index. Manufacturers must demonstrate consistent potency, stability, and bioavailability to gain FDA approval. Given that 63.6% of India's levothyroxine exports are destined for the U.S., and with 125 active Indian exporters, compliance with FDA regulations is paramount to maintain market access and ensure patient safety.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, levothyroxine is subject to rigorous regulatory oversight. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) require comprehensive data on quality, safety, and efficacy for marketing authorization. Notably, in October 2012, the EMA's Committee for Medicinal Products for Human Use (CHMP) concluded that the benefits of Levothyroxine Alapis did not outweigh its risks, leading to the denial of marketing authorization in several EU Member States. (ema.europa.eu)

EU Good Manufacturing Practice (GMP) guidelines mandate that manufacturers adhere to high standards in production processes, quality control, and documentation. For Indian exporters, compliance with these GMP requirements is essential to access and sustain a presence in the European and UK markets.

3WHO Essential Medicines & Global Standards

Levothyroxine is listed in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, underscoring its critical role in global health. (who.int) This inclusion highlights the medication's importance in treating thyroid disorders worldwide. While the WHO Prequalification Programme primarily focuses on medicines for HIV, tuberculosis, malaria, and reproductive health, the listing of levothyroxine emphasizes its essential status.

Pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) provide detailed monographs for levothyroxine, ensuring consistency in quality and efficacy across different markets.

4India Regulatory Classification

In India, levothyroxine is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), regulates the pricing of essential medicines. As of March 2026, levothyroxine is subject to price controls to ensure affordability. For exports, the Directorate General of Foreign Trade (DGFT) requires a No Objection Certificate (NOC) to monitor and regulate the export of pharmaceuticals, ensuring that domestic needs are met before permitting international shipments.

5Patent & Exclusivity Status

The patent landscape for levothyroxine varies by formulation and jurisdiction. For example, the oral solution formulation Ermeza is protected under U.S. Patent No. 9,345,772, issued on May 24, 2016, with an expiry date of February 27, 2035. This patent protection limits generic competition for specific formulations, influencing market dynamics and pricing strategies.

6Recent Industry Developments

In September 2025, the WHO updated its Model List of Essential Medicines, reaffirming levothyroxine's inclusion and emphasizing its continued importance in global health. (who.int)

In November 2019, the EMA conducted a periodic safety update report single assessment (PSUSA) for levothyroxine, leading to variations in product information to enhance patient safety. (ema.europa.eu)

These developments underscore the dynamic regulatory environment surrounding levothyroxine, necessitating continuous monitoring and compliance by manufacturers and exporters to maintain market access and ensure patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Levothyroxine

Retail & reference prices across 9 markets vs. India FOB export price of $1.77/unit

Global Price Benchmark for Levothyroxine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA's Orange Book, levothyroxine is available in multiple generic formulations, contributing to its affordability.
United Kingdom	$0.13	GBP	The NHS Drug Tariff lists levothyroxine as a standard treatment for hypothyroidism, ensuring its availability at regulated prices.
Germany	$0.22	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates medication pricing, including levothyroxine, to maintain affordability.
Australia

Supply Chain Risk Assessment — Levothyroxine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Levothyroxine, a critical medication for thyroid disorders, relies heavily on Active Pharmaceutical Ingredients (APIs) sourced from India. However, India's API production is significantly dependent on Key Starting Materials (KSMs) imported from China. According to the U.S. Pharmacopeia, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting a substantial supply chain vulnerability.

This dependency has led to supply chain disruptions in the past. For instance, in July 2018, environmental regulations in China resulted in the shutdown of several chemical plants, causing a ripple effect that impacted Indian pharmaceutical manufacturers reliant on Chinese KSMs. Such events underscore the fragility of the supply chain for essential medications like levothyroxine.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters account for 77.8% of levothyroxine exports, with MACLEODS PHARMACEUTICALS LTD alone contributing 32.9%. This high concentration poses a significant single-source risk, as any disruption within these key suppliers could severely impact global supply.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme for bulk drugs, aiming to boost domestic manufacturing and reduce import dependence. By March 2025, the scheme had led to import savings of ₹1,362 crore and the creation of domestic manufacturing capacity for 25 identified KSMs, DIs, and APIs. However, the effectiveness of this scheme in diversifying levothyroxine suppliers remains to be fully realized.

Access Complete Levothyroxine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,385 transactions across 71 markets.

Request Demo View Pricing

Frequently Asked Questions — Levothyroxine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top levothyroxine exporters from India?

The leading levothyroxine exporters from India are MACLEODS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, STERIL-GENE LIFE SCIENCES PRIVATE LIMITED, and 12 others. MACLEODS PHARMACEUTICALS LTD leads with 32.9% market share ($25.6M). The top 5 suppliers together control 77.8% of total export value.

What is the total export value of levothyroxine from India?

The total export value of levothyroxine from India is $77.7M, recorded across 2,385 shipments from 125 active exporters to 71 countries. The average shipment value is $32.6K.

Which countries import levothyroxine from India?

India exports levothyroxine to 71 countries. The top importing countries are UNITED STATES (63.6%), PERU (11.6%), UNITED KINGDOM (8.8%), AUSTRALIA (6.9%), CHILE (2.4%), which together account for 93.3% of total export value.

What is the HS code for levothyroxine exports from India?

The primary HS code for levothyroxine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Levothyroxine

Levothyroxine

Top Levothyroxine Exporters from India

Top Countries Importing Levothyroxine from India

Who Supplies Levothyroxine to India?

Quick Facts

Related Diabetes & Endocrine

Related Analysis

Need Details?

Levothyroxine — Export Intelligence Video

Regulatory Landscape — Levothyroxine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Levothyroxine

Supply Chain Risk Assessment — Levothyroxine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Levothyroxine Trade Intelligence

Frequently Asked Questions — Levothyroxine Exports from India

Who are the top levothyroxine exporters from India?

What is the total export value of levothyroxine from India?

Which countries import levothyroxine from India?

What is the HS code for levothyroxine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of levothyroxine exports from India?

Which ports handle levothyroxine exports from India?

Why is India a leading exporter of levothyroxine?

What certifications do Indian levothyroxine exporters need?

How many buyers import levothyroxine from India?

What is the market share of the top levothyroxine exporter from India?

Analysis Methodology